Cargando…
Provocative testing using low dose oral flecainide for diagnosis of Brugada syndrome: a report of two cases
BACKGROUND: Brugada syndrome (BrS) is a genetic disease characterized by coved ST-segment elevation in the right precordial leads that predispose to life-threatening ventricular tachyarrhythmia. The electrocardiographic signature is dynamic and often concealed but can be unmasked by potent sodium ch...
Autores principales: | Amir, Muzakkir, Kabo, Peter, Rahma, Iznaeny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897198/ https://www.ncbi.nlm.nih.gov/pubmed/36751482 http://dx.doi.org/10.1093/ehjcr/ytac460 |
Ejemplares similares
-
Exercise Testing With Flecainide Demonstrates Provocable Brugada Syndrome
por: Safabakhsh, Sina, et al.
Publicado: (2021) -
Utility of Oral Quinine Sulfate for the Treatment of Brugada Syndrome Presenting as Electrical Storm in Remote Areas: Resilience in the COVID-19 Era
por: Amir, Muzakkir, et al.
Publicado: (2021) -
Epicardial mapping and ablation of the right ventricle substrate during flecainide testing in Brugada syndrome
por: Gonzalez-Melchor, Laila, et al.
Publicado: (2015) -
Evaluation of baseline ECG in patients undergoing Oral Flecainide Challenge test for suspected Brugada Syndrome: An analysis of lead II
por: Rai, Maneesh K., et al.
Publicado: (2017) -
Positive Ajmaline provocation test for Brugada syndrome: acute and long-term outcomes
por: Sabbag, A, et al.
Publicado: (2023)